SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 230 filers reported holding SAGE THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $276,000 | -48.8% | 3,200 | -83.0% | 0.23% | -20.3% |
| Q1 2020 | $539,000 | -89.4% | 18,800 | -32.6% | 0.29% | -19.2% |
| Q2 2019 | $5,108,000 | +248.7% | 27,900 | +82.4% | 0.35% | +250.5% |
| Q4 2018 | $1,465,000 | +48.3% | 15,300 | +118.6% | 0.10% | +77.2% |
| Q3 2018 | $988,000 | -77.3% | 7,000 | -90.0% | 0.06% | -75.5% |
| Q3 2017 | $4,354,000 | -21.8% | 69,900 | 0.0% | 0.23% | -32.1% |
| Q2 2017 | $5,566,000 | +36.2% | 69,900 | +21.6% | 0.34% | +32.9% |
| Q1 2017 | $4,086,000 | +1031.9% | 57,500 | +379.2% | 0.26% | +658.8% |
| Q2 2016 | $361,000 | -82.8% | 12,000 | -81.7% | 0.03% | -84.0% |
| Q1 2016 | $2,099,000 | +443.8% | 65,500 | +750.6% | 0.21% | +292.6% |
| Q1 2015 | $386,000 | +57.6% | 7,700 | +14.9% | 0.05% | +31.7% |
| Q4 2014 | $245,000 | – | 6,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |